baber/WOPTO huggingface dataset:
Patent NZ-285667-A (NZ)
Title: Ozone water treatment and solids separation apparatus
Inventor: UBAN STEPHEN A
IPC: C02F1/78
Filed: 1995-05-12
Abstract: An apparatus for treating water includes a vertically extending contact vessel, wherein water is contacted with ozone, and a return vessel which contains a column of water of a sufficient height to drive water through downstream filtering stages. Ozone is removed from the water and the rate of ozone injection is monitored and automatically adjusted so that no great amount of ozone remains in water entering the filtering stages. The ozone is generated in elongated elements that are cooled by the process water and that are positioned to serve as a static mixer for such water.
Patent NZ-290804-A (NZ)
Title: Various 2-hydroxymethylphenylglyoxalic acid o-fluoromethyl oxime derivatives and 2-(halo)methylphenylglyoxalic acid ester o-fluoromethyl oxime intermediates
Inventor: PFIFFNER ALBERT
IPC: A01N43/08
Filed: 1995-07-21
Abstract: Compounds of formula I are suitable for controlling and preventing infestation by microorganisms, insects and acarina on plants    <IMAGE>  (I)  and their possible isomers and mixtures of isomers, wherein a) X is CH2F or CHF2,  Y is CH and  Z is OCH3, or b) X is CH2F or CHF2,  Y is a nitrogen atom and  Z is OCH3 or NHCH3, and wherein R1 and R2 are each independently of the other hydrogen, cyano, C1-C12alkyl, halo-C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, C3-C6cycloalkyl, cyclopropylmethyl, C1-C4alkoxy, C2-C12alkoxyalkyl, C1-C4alkoxycarbonyl, C1-C4alkylthio, C2-C5alkylthioalkyl; or an unsubstituted or mono- to tri-substituted ring having not more than 15 ring carbon atoms that may be multi-membered and that contains from 0 to 3 hetero atoms N, O or S, it being possible for that ring to be bonded via an aliphatic bridge having not more than 4 carbon atoms and/or via CO, oxygen or sulfur, as desired; or wherein R1 and R2 together with their common carbon atom form an unsubstituted or mono- to tri-substituted ring having not more than 15 ring carbon atoms that may be multi-membered and that contains from 0 to 3 hetero atoms N, O or S. They can be used in the form of commercially customary formulated compositions.
Patent NZ-331840-A (NZ)
Title: Improvements in or relating to non-gelatin encapsulation
Inventor: BROWN MALCOLM DAVID
IPC: B65B11/50
Filed: 1997-03-25
Abstract: The specification describes a method of non-gelatin encapsulation. The method is characterised by supplying to an encapsulation unit (22) two films (14, 16) of like material capable of deforming elastically at least when partially solvated, and applying solvent to at least one of the films prior to encapsulation to cause partial solvation of the material surface. The partially solvated surface can adhere to and seal with the film material. In the encapsulation unit, the substance to be encapsulated e.g. a cosmetic oil or vitamin preparation is supplied between the films, the films are formed, typically by a moulding process, into suitably shaped capsule portions which can adhere to each other as a result of the adhesive action of the partially solvated surface(s), and which seal together encapsulating the supplied substance, forming a capsule. The invention enables encapsulation using materials other than gelatin, such as polyvinyl alcohol. Also disclosed is encapsulation apparatus and the resulting capsules.
Patent NZ-335591-A (NZ)
Title: Composition and method for treating plants with exogenous chemicals
Inventor: GILLESPIE JANE L
IPC: A01N25/28
Filed: 1997-10-24
Abstract: Methods and compositions are disclosed wherein exogenous chemicals are applied to plants to generate a desired biological response. One embodiment of the present invention is a plant treatment composition that comprises: (a) a water-soluble exogenous chemical such as herbicides, algicides, fungicides, bactericides, viricides, insecticides, aphicides, miticides, nematicides, molluscicides, plant growth regulators, fertilizers and nutrients, gametocides, defoliants, desiccants and mixtures thereof. (b) a first excipient substance which is propyl, isopropyl or butyl ester of a C12-18 fatty acid and (c) a second excipient substance which is an amphiphilic substance having a critical packing parameter greater than one third, wherein the weight/weight ratio of the first excipient substance to the exogenous chemical is from about 1:3 to about 1:1000. Also disclosed is a plant treatment method comprising the steps: a) contacting foliage of the plant with a biologically effective amount of an exogenous chemical and b) contacting the same foliage with the above composition.
Patent NZ-336124-A (NZ)
Title: 5-aralkyl or (aryl, heteroaryl or heteroarylalkyl) substituted pyrrolo[3,4-d]pyrimidinone derivatives and medicaments
Inventor: COOPER MARTIN
IPC: C07D487/04
Filed: 1997-12-18
Abstract: There is provided certain 5-substituted pyrrolo[3,4-d]pyrimidine-2,4-diones according to the general formula (I), processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and the use of the compounds of formula (I) for the manufacture of medicaments for use in therapy. wherein W represents --CH2 - or a bond; Q represents Ar1 or Ar2 ; in the case where W represents --CH2 -, Q represents an aryl group Ar1 wherein Ar1 represents naphthyl, phenyl, quinolyl, isoquinolyl, indolyl, benzofuranyl or benzothienyl; in the case where W represents a bond, Q represents an aryl group Ar2 wherein Ar2 represents acenaphthenyl, fluorenyl or indanyl; wherein the ring systems which Ar1 and Ar2 represent may all be optionally substituted by one or more substituents selected from C1-4 alkyl, C1-4 alkoxy, halogen, or trifluoromethyl; R10 represents X-(A)p -Y; X represents S(O)n, CºC, (CH2)2, CH=CH or CH2CH=CH; n represents 0, 1 or 2; A represents C1-6 alkylene; p is 0 or 1; Y represents CN, OR11, CO2 R12, CONR13 R14, NR15 R16, NHSO2 R17, NHCOR18 or an optionally substituted aryl or heteroaryl group, provided that when X represents S(O)n and Y is other than an optionally substituted aryl or heteroaryl group, then p is 1 and also provided that when X represents S(O)n, p is 1 and Y represents OH, then n is not 0; R13 and R14 independently represent H, C1-5 alkyl or phenyl, which latter group may be substituted by one or more substituents selected from C1-4 alkyl, C1-4 alkoxy, halogen, or CO2 R21 ; and R1, R2, R11, R12, R15, R16, R17, R18, and R21 independently represent H or C1-5 alkyll; or a pharmaceutically acceptable salt thereof.
Patent NZ-336472-A (NZ)
Title: Hydraulic apparatus typically for grapple rotary union with fluid leaking in to space between high and low pressure seals being directed via pressure relief valve back to reservoir
Inventor: SHARP RODNEY
IPC: F16J15/00
Filed: 1999-06-24
Abstract: Hydraulic fluid leakage from high pressure seals 5 is prevented from leaking via lower pressure seals 4 by pressure release valve 7 located in a path between the two sets of seals.
Patent NZ-513053-A (NZ)
Title: (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
Inventor: EMONDS-ALT XAVIER
IPC: C07D267/00
Filed: 2000-02-08
Abstract: Piperidine derivatives of formula (I) and processes for their preparation.  These compounds exhibit a high affinity and high selectivity for tachykinin (NK) receptors.  Also described are pharmaceutical compositions containing said compounds, for use in treating diseases mediated via the tachykinin receptor pathway.
Patent NZ-515388-A (NZ)
Title: Polynucleotides and polypeptides used to stimulate leukocyte growth and to modulate angiogenesis and treat neurological conditions
Inventor: WATSON JAMES D
IPC: A61K48/00
Filed: 2000-05-15
Abstract: Described  are polypeptides expressed in  skin  cells, together  with  polynucleotides encoding  the  polypeptides, expression   vectors   and   host   cells   comprising   the polynucleotides, and methods for their use. The  isolated  polypeptides comprising amino acid  sequences are  useful in the production of medicaments for stimulating keratinocyte growth and motility, inhibiting the  growth  of epithelial-derived  cancer  cells,  stimulating  growth   of epithelial     cells,    inhibiting     angiogenesis     and vascularisation  of  tumours, or modulating  the  growth  of blood  vessels in a subject, inhibiting the binding of HIV-1 to  leukocytes and for treating the inflammatory disease  in a  patient.   Moreover  the use of a composition  comprising the  isolated polypeptides and amino acid sequences  in  the preparation  of  a  medicament for  treating  cancer  and  a neurological disease in a patient is also described. The  isolated polynucleotides and polypeptides may  be  also used  in  the  preparation  of therapeutic  agents  for  the treatment of skin disorders.
Patent NZ-515918-A (NZ)
Title: High purity (1R,2S,4R)-(-)-2- [(2'-{N,N- dimethylamino} - ethoxy)] -2-[phenyl] -1,7,7-tri-[methyl] -bicyclo[2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof and a process for the preparation of these compounds as well as medicaments containing 1 or more of these compounds
Inventor: LUKACS GYULA
IPC: A61K31/13
Filed: 2000-05-10
Abstract: The invention relates to a process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof with higher yields and higher grades of purity.
Patent NZ-516540-A (NZ)
Title: A non-return valve
Inventor: HORTON DAVID
IPC: F16K15/20
Filed: 2000-06-14
Abstract: A non-return valve (10), typically of commonly called duckbill valve shape, comprising a valve body (12) and a valve membrane (14). The valve body (12) is generally tubular and includes an elongate passageway (16) with inlet (18) and outlet (20) at opposing ends. The valve membrane (14) is of a generally conical-shaped diaphragm formed integrally with the valve body (12). The diaphragm (14) has a collapsible opening or aperture (22) located at or adjacent the cones apex. The conical diaphragm (14) is oriented with its apex pointing downstream. The resiliently flexible material from which the diaphragm (14) is constructed, ensures that the diaphragm (14) in a collapsed condition obstructs or closes the aperture (22) to prevent fluid flowing in a reverse direction, i.e. backflow towards the inlet. Pressurisation of fluid within the passageway (16) on the inlet (18) side of the diaphragm (14), deflects the diaphragm to open the aperture (22) so that fluid can flow through the passageway from the inlet (18) to the outlet (20) only. A membrane permeable in one direction only can also be made from a panel or sheeting incorporating many such collapsible non-return duckbill valves on the surface of the panel or sheet.
Patent NZ-517837-A (NZ)
Title: An apparatus for sorting timber
Inventor: GUNNARSSON CENNETH
IPC: B07C5/14
Filed: 2000-09-11
Abstract: An  apparatus for sorting individual timber pieces  of different  dimensions  and/or qualities  into  a  number  of mutually  superposed sorting compartments  (1)  comprises  a conveyor   and   a  transfer  device  (12).   The   conveyor transports   individual  timber  pieces  in   the   vertical direction  along the infeed ends of the sorting compartments (1).  The  longitudinal direction of the  timber  pieces  is approximately  horizontal  and  transversely   directed   in relation  to  the  longitudinal  direction  of  the  sorting compartments  (1).  The  transfer device  (12)  transfers  a specific  timber  piece  from the  conveyor  to  a  specific sorting  compartment (1). The transfer device  (12)  has  at least one transfer member (13) per sorting compartment  (1). Each  transfer  member  (13) is movable  between  a  passive position outside the path (4) of the conveyor and an  active position  within the path (4) of the conveyor. The path  (4) of  the  conveyor is substantially vertical and  rectilinear and  located  a distance (11) from the infeed  ends  of  the sorting compartments (1).
Patent NZ-520487-A (NZ)
Title: Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
Inventor: HOMAN REYNOLD
IPC: A61K31/27
Filed: 2002-07-31
Abstract: The use of a compound of formula (II) in the manufacture of a medicament for inhibiting sebum production in a subject, the compound being capable of inhibiting the acyl-Coenzyme A:fatty alcohol acyltransferase activity of a mammalian AFAT enzyme, wherein X and Y are selected from oxygen, sulfur, nitrogen and -(CR'R")n-, and the remaining substituents are defined herein.
Patent NZ-521767-A (NZ)
Title: Flat panel sound radiator with extended bass response and low self noise
IPC: H04R7/02
Filed: 2002-10-03
Abstract: A flat panel sound radiator (11) with enhanced audio performance, said flat panel sound radiator (11) comprising: a panel (12) having a core (18) of a first material sandwiched between facing skins of a second material (19, 21), said facing skins (19, 21) being secured to said core (18) with an adhesive; an exciter (22) coupled to said panel (11) for imparting vibrations corresponding to audio program material to said panel (11); said second material having a Young's modulus and a tan delta each sufficiently high such that said flat panel sound radiator (11), when subjected to a spectral contamination test, exhibits a signal-to-noise greater than 40dB for an input signal of 85dB within a frequency range from about 1 kHz to about 10 kHz.
Patent NZ-521995-A (NZ)
Title: E-commerce transaction facilitation system and method
Inventor: FEAVER DONALD PETER
IPC: G06Q30/06
Filed: 2001-03-16
Abstract: A method of facilitating an e-commerce transaction, the method including: providing a set of trading parameters; accepting in respect of a first entity (3) a desired trading profile including desired values or ranges of multiple of said trading parameters; and accepting in respect of said first entity (3) one or more further trading profiles including values or ranges of multiple of said trading parameters; establishing one or more functional relationships between variations in a key trading parameter and one or more other of said trading parameters; wherein each of said further trading profiles are equivalent in desirability or expected value to said desired trading profile, and said functional relationship can be used to determine a set of equivalent trading profiles having substantially desirability equal expected values equivalent to said desired trading profile and said further trading profiles.
Patent NZ-522846-A (NZ)
Title: Automatically establishing control values for potentiometer for barrier operation e.g. a garage door by initiating learning mode
Inventor: KELLER ROBERT R
IPC: E05F15/10
Filed: 2002-11-28
Abstract: A movable barrier controller (41) has a force control (44) having a corresponding setting range. As operating conditions change, the barrier controller (41) can execute a learning mode (51). During this mode, the barrier controller (41) operates the barrier movement motor (42) and measures at least one parameter (53) that corresponds to operation of the motor (42). This measured parameter is used to determine (54), a control value, which is then assigned to a specific location within the setting range (55) of the force control (44).
Patent NZ-523079-A (NZ)
Title: Wearable projector and intelligent clothing
Inventor: REHO AKSELI
IPC: A61B5/00
Filed: 2001-05-11
Abstract: A projector 202 is mounted on a garment of a user and connected to receive data for display from a portable electronic device such as a GPS receiver, a PDA or a mobile telephone. The image of the data can be projected by the projector onto walls, the ground, or the user's hand to be viewed by the user.
Patent NZ-523721-A (NZ)
Title: UV-irradiation device for treating fluids, comprising an improved cleaning device
Inventor: MENKE GERHARD
IPC: B01J19/12
Filed: 2002-01-10
Abstract: Disclosed is a UV-irradiation device for treating fluids, comprising an improved device for cleaning the surfaces of the jacket tubes. The UV-irradiation device comprises a number of lamp units, each having a radiation source and a jacket tube (3) that surrounds the radiation source, the lamp units being essentially cylindrical and a cleaning device, which has cleaning elements (1) that encompass the jacket tubes in the form of a ring. At least one cleaning element is allocated to each jacket tube and the cleaning elements of at least one drive unit can be displaced in the longitudinal direction of the jacket tubes. The cleaning elements have an axially delimited annular chamber, which is open towards the surface of the jacket tubes. At least one ring consisting of a rubber-type elastic material lies in the chamber. The internal diameter of the ring in an unstressed condition is less than or equal to the external diameter of the jacket tube.
Patent NZ-524390-A (NZ)
Title: Purine ribosides as antiarrhythmics
Inventor: WOLFF ANDREW A
IPC: A61P9/06
Filed: 2001-09-07
Abstract: The application discloses the use of Formula I, an adenosine A1 receptor agonist, in the manufacture of a medicament for the treatment of arrhythmia in a mammal. R1 is an optionally substituted heterocyclic group and the said medicament is formulated for an administration dose range within 0.003-0.009 mg/kg.
Patent NZ-529171-A (NZ)
Title: Reducing sulfur dioxide emissions from coal combustion
Inventor: HOLCOMB ROBERT R
IPC: C10L5/00
Filed: 2002-03-28
Abstract: Disclosed herein is a process of treating high sulfur coal to reduce sulfur dioxide emission when the high sulfur coal is burned, which comprises placing coal in pressure tank (16) of reduced pressure sufficient to fracture a portion of the coal by withdrawing ambient fluids trapped within the coal. The fractured coal is contacted with an aqueous silica colloid composition supersaturated with calcium carbonate via conduit (21), and the majority of the aqueous composition is then removed from contact with the coal. The aqueous composition-treated coal is pressurized in pressure tank (16) under a carbon dioxide atmosphere for a period of time sufficient for the calcium carbonate to enter fractures in the coal produced in the first step.
Patent NZ-533699-A (NZ)
Title: 6-fluorobicyclo[3.1.0]hexane derivatives
Inventor: NAKAZATO ATSURO
IPC: C07D333/16
Filed: 2002-12-26
Abstract: Disclosed is a 2-amino-3-alkoxy-6-fluorobicyclo[3.1.0] hexane-2,6-dicarboxylic acid derivative of formula [I], where R1 - R5 are as defined in the specification. The disclosed compound is useful as a group II metabotropic glutamate receptor antagonist. In particular the compound is useful for treating psychiatric diseases exemplified by schizophrenia, anxiety, bipolar disorder and epilepsy; and neurological diseases exemplified by drug dependence, cognitive disorders, Alzheimer's disease, Huntington's chorea and Parkinson's disease amongst others.
Patent NZ-533959-A (NZ)
Title: Microwaveable package without the need of puncturing the packaging prior to heating
Inventor: PHEE BOON EOW
IPC: B65D75/30
Filed: 2002-05-13
Abstract: The dislcosure relates to the application of flexible or diffusible films (130) to form an openable sealing means on packages (100). In particular, the disclosure relates to the application of flexible or diffusible films (130) to form an openable sealing means on packages for containing food that are intended to be being heated by microwave ovens. The current invention is stated to be a simpler and more convenient solution to contain the food by packaging that will enable the food to be heated without the need of puncturing the packaging prior to heating.
Patent NZ-540992-A (NZ)
Title: Rotary impulse sealer
Inventor: O'DOWD ROBERT J
Filed: 2005-06-29
Abstract: A rotary impulse sealer for sealing of heat-sealable materials is disclosed. The sealer includes a rotatable roll with at least one heating zone and at least one cooling zone. The heating zone has a resistive area 20 in electrical contact with a conductive zone 25. A current source 62 is connected to the conductive zone 25 and flows into the resistive zone to create heating. The cooling zone is defined by the absence of any heating. The heat sealable material forms a heat seal on contact with the heating zone and is cooled in a supported state on contact with the cooling zone.
Patent NZ-541504-A (NZ)
Title: Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use
Inventor: ANANTHARAMIAH GATTADAHALLI M
IPC: C07K14/775
Filed: 2003-11-13
Abstract: Disclosed is a synthetic apolipoprotein-E mimicking polypeptide comprising an amino acid sequence selected from the group of (i) X-Y-Arg-Arg-Y-Y-X-X-Y-Y-Arg-Y-Y-Arg-X-Y-Y-X or the reverse sequence thereof, (ii) Arg-Arg-Y-Y-X-X-Y-Y-Arg-Y-Y-Arg-X-Y or the reverse sequence thereof, (iii) Y-Y-X-X-Y-Y-Arg-Y-Y-Arg-X-Y-Y-X or the reverse sequence thereof, and (iv) X-Y-Arg-Arg-Y-Y-X-X-Y-Y-Arg-Y-Y-Arg or the reverse sequence thereof, wherein X is glycine, threonine, serine or alanine, wherein Y is a hydrophobic amino acid, wherein the polypeptide comprises an acetyl group at the N terminus and an amide group at the C-terminus, and wherein the polypeptide consists of a single domain.
Patent NZ-542302-A (NZ)
Title: Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention
Inventor: HILBRICH LUTZ
IPC: A61K31/41
Filed: 2004-02-10
Abstract: Disclosed is a pharmaceutical composition comprising (a) dipyridamole or a pharmaceutically acceptable salt thereof, (b) acetylsalicylic acid (ASA or aspirin) and (c) an angiotensin II antagonist selected from the group consisting of candesartan, eprosartan, irbesartan, losartan, telmisartan, valsartan, olmesartan and tasosartan, including the salts thereof or polymorphs thereof, wherein compounds (a), (b) and (c) of the composition are adapted to be administered simultaneously, separately or sequentially.
Patent NZ-543908-A (NZ)
Title: Device for manufacturing a double-walled thermoplastic pipe with a connecting sleeve
Inventor: LUPKE MANFRED ARNO ALFRED
IPC: B29C48/09
Filed: 2004-06-23
Abstract: A device for manufacturing a double-walled thermoplastic pipe with a connecting sleeve is disclosed. When a pipe is produced using this device, an approximately ring-shaped space (A) is defined by an injection head (1), a first flexible tube (2) extruded in a moulding tunnel (4), and a second flexible tube (5) extruded in the first flexible tube (2). According to the invention, the space (A) is in communication with a compressed gas reservoir (24), thus making it possible to attenuate pressure fluctuations in the space (A) by means of the compressed gas container.
Patent NZ-548236-A (NZ)
Title: Compositions comprising (2S.3S) (2-benzhydryl-1-aza-bicyclo[2.2.2]oct-3-yl)-(5-alkyl-2-methoxy-benzyl)-amine derivatives
Inventor: ADAMI ROGER CHRISTOPHER
IPC: A61K47/48
Filed: 2005-01-17
Abstract: Disclosed is a parenteral pharmaceutical composition with injection site toleration comprising a therapeutically effective amount of a (2S,3S) (2-benzhydryl-1-aza-bicyclo[2.2.2]oct-3-yl)-(5-alkyl-2-methoxy-benzyl)-amine derivative of formula (I) or a pharmaceutically acceptable salt thereof, the composition further comprising a beta-cyclodextrin (such as suIfobutylether-beta-cyclodextrin), a pharmaceutically acceptable preservative, and a pharmaceutically acceptable vehicle, wherein the preservative is meta-cresol or thimerosal, where R2 is methyl, ethyl, isopropyl, sec-butyl, or tert-butyl, and the preservative demonstrates pharmaceutically acceptable antimicrobial preservative effectiveness. Also disclosed is the use of the above pharmaceutical composition in the manufacture of a medicament for the treatment of emesis in a non-human mammal, and a method for the treatment of emesis in a non-human mammal comprising administering to said non-human mammal in need of such treatment a therapeutically effective amount of the above pharmaceutical composition is further disclosed.